The present invention relates to a system comprising a pharmaceuticalcomposition comprising a purified, stable, active alpha- 1 proteinaseinhibitor (API) in a form of a ready to use sterile solution and an inhalationnebulizer, and to methods of use thereof for treating pulmonary diseases.